No live calls today · full consensus board · graded history
Price (daily close, 2026-08-24)
Recent news
| 2026-08-25 | BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan - markets.businessinsider.com · markets.businessinsider.com |
| 2026-08-25 | BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan · globe_newswire |
| 2026-08-21 | Haemonetics: Worth Speculating On This Recurring Medtech Plasma Model · seeking_alpha |
| 2026-08-18 | Haemonetics Corporation Stock 12‑Month Price Target Raised to $101.8, Implies 13% Upside - TradingView · TradingView |
| 2026-08-18 | Haemonetics stock surges 16% on CSL Plasma supply deal - Investing.com · Investing.com |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。